Dr. Barbara Rehermann is Chief of the Immunology Section, Liver Diseases Branch, NIDDK at the National Institutes of Health in Bethesda, Maryland, USA. She received an M.D. degree and the Venia Legendi for Immunology from Medizinische Hochschule, Hannover, Germany, and pursued clinical training in the Department of Gastroenterology, Hepatology and Endocrinology at the same university, and postdoctoral research at The Scripps Research Institute, La Jolla, USA.

Barbara Rehermann to give the 2024 Philip I Marcus Memorial Symposium Lecture

Barbara Rehermann, MD, Chief of the Immunology Section, Liver Diseases Branch, NIDDK at the National Institutes of Health has been chosen as Memorial Lecturer to speak at the Philip I. Marcus Memorial Symposium 4: Host-microbiota Interaction “Wild-derived microbiota regulate host immune responses and disease outcome in preclinical models” at Cytokines 2024 in Seoul.

Curt M. Horvath, PhD Professor of Molecular Biosciences Biochemistry, Molecular Biology and Cell Biology Northwestern University Department of Molecular Biosciences Evanston, USA

3rd Annual Jürg Tschopp Memorial Lecture to be given by Curt Horvath at Cytokines 2024 in Seoul

Each year the Jürg Tschopp Memorial Symposium will be a highlight of the Cytokines Annual Meeting in memory of Professor Jürg Tschopp whose discoveries in the area of inflammasomes and cell death advanced fundamental understanding of innate and adaptive immunity bringing new therapies to patients suffering from debilitating inflammatory diseases. Curt Horvath’s Lecture, “Positive and negative regulation of interferon signaling and antiviral immunity”, is representative of Dr. Tschopp’s ability to take fundamental discoveries at the bench into the clinic.

2024 ICIS-Pfizer Trainee Award Winners

Announcing the ICIS-Pfizer Trainee Awards for Most Promising Research Presentations at Cytokines 2024

Introducing the four (4) ICIS Student/Postdoc Members with the highest scoring abstracts as per the scientific review committee. Each will be awarded $1,250 and will be presenting an oral presentation or lightning talk at Cytokines 2024 in Seoul at the joint meeting with KAI and recognized as a Pfizer Trainee Presentation, in the most appropriate session based on topic.